We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 11,276.00 | 11,314.00 | 11,320.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8406 | 29.47 | 174.84B |
From Feb 2020 to Feb 2025
International stocks trading in New York closed mostly higher on Thursday.
The BNY Mellon index of American depositary receipts edged up 0.15% to 133.68. The European index improved 0.27% to 125.04 and the Asian index increased 0.20% to 152.63.
Meanwhile, the Latin American index fell 1.1% to 232.72, and the emerging-markets index eased 0.08% to 272.23.
Shire PLC (SHPG, SHP.LN) was among the companies with ADRs that traded actively.
AstraZeneca PLC (AZN, AZN.LN), BP PLC (BP, BP.LN) and Royal Dutch Shell PLC (RDSA, RDSA.LN, RDSB, RDSB.LN) were among the companies with ADRs trading in New York that began trading ex-dividend. The ex-dividend date is the usually-day-long period in which investors cannot buy a stock and still receive its dividend, said Accendo Markets analyst Michael van Dulken. ADRs of AstraZeneca fell 0.28% to $28.76, BP's fell 0.36% to $33.68, and Royal Dutch Shell's fell 0.77% to $52.96.
Dublin-based drug maker Shire's fourth-quarter profit surged as its recently acquired Baxalta business added about $1.8 billion in revenue. ADRs rose 2.6% to $178.70.
Turkey's biggest mobile phone operator Turkcell's (TKC, TCELL.IS) revenue and earnings before interest, taxes, depreciation and amortization, or Ebitda--a common measure of cash flow--beat analysts' consensus in the most recent period. ADRs rose 2.3% to $7.72.
(END) Dow Jones Newswires
February 16, 2017 16:43 ET (21:43 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
